Join to View Full Profile
Elm and Carlton StBuffalo, NY 14263
Phone+1 716-845-2300
Fax+1 716-845-2300
Dr. Fujiwara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Hematology/Oncology fellow at Roswell Park Comprehensive Cancer Center
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 2023 - 2026
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2020 - 2023
The Cancer Institute Hospital of Japanese Foundation for Cancer ResearchMedical Oncology, Medical Oncology, 2019 - 2020- Musashino Red Cross HospitalMedical Oncology, Medical Oncology, 2018 - 2020
- Musashino Red Cross HospitalInternal Medicine, 2017 - 2018
- Keio University HospitalTwo-year internship, 2015 - 2017
Keio Gujuku University School of MedicineClass of 2015
Certifications & Licensure
NY State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine
Japanese Society of Internal MedicineBoard Certification- Japanese Society of Medical OncologyDiplomate, Subspecialty Board of Medical Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha membership Alpha Omega Alpha Honor Medical Society, 2023
- Most Outstanding Poster Award Annual Meeting of Japanese Society of Hospital General Medicine, 2018
- Keio University Scholarship Keio University, 2012
Publications & Presentations
PubMed
- Encouraging co-targeting of immunoregulatory molecules in cancer treatment.Takumi Sato, Yu Fujiwara
Immunotherapy. 2025-02-01 - 2 citationsConsolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC.Amin H Nassar, Ritujith Jayakrishnan, Jamie Feng, Frances Shepherd, Elio Adib
Journal of Thoracic Oncology. 2025-01-01 - Prognosis and tumor microenvironment in pseudohypoxic pheochromocytoma/paraganglioma.Akihiro Ohmoto, Yasuyuki Shigematsu, Rumiko Saito, Akito Dobashi, Yu Fujiwara
Virchows Archiv. 2024-12-19
Press Mentions
Experts Available and Research to Be Presented in Bladder Cancer, Disparities in Cancer and Other Areas at the 2021 ASCO Annual MeetingMay 19th, 2021
Adverse Events up with Immune Checkpoint Blockade Added to Periop Cancer TherapyDecember 8th, 2023
Professional Memberships
- Member
- Society for Immunotherapy of CancerMember
- European Society of Medical OncologyMember
- Japanese Society of Medical OncologyMember
- Japanese Society of Internal MedicineMember
- Japanese Cancer AssociationMember
- Member
Other Languages
- Japanese
External Links
- Google Scholarhttps://scholar.google.co.jp/citations?user=IfqWWvYAAAAJ&hl=ja
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
